SYSTEMIC LIGHT CHAIN AMYLOIDOSIS
Clinical trials for SYSTEMIC LIGHT CHAIN AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC LIGHT CHAIN AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for SYSTEMIC LIGHT CHAIN AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare amyloidosis: experimental drug targets blood protein
Disease control Recruiting nowThis study tests an experimental drug called TQB2934 in 70 adults with systemic light chain amyloidosis, a rare disease where abnormal proteins build up in organs. The goal is to see if the drug can improve blood markers and is safe for people who have already tried other treatme…
Matched conditions: SYSTEMIC LIGHT CHAIN AMYLOIDOSIS
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
New antibody therapy shows promise for rare amyloidosis
Disease control Recruiting nowThis study tests a new drug called CM336, a bispecific antibody, in 21 people newly diagnosed with a rare disease called AL amyloidosis. The goal is to see if the drug can improve blood markers of the disease and to check for side effects. Participants will receive the drug and b…
Matched conditions: SYSTEMIC LIGHT CHAIN AMYLOIDOSIS
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 19, 2026 11:47 UTC